• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

VIPR1 基因调控人肺腺癌细胞 H1299 的机制。

Mechanism of VIPR1 gene regulating human lung adenocarcinoma H1299 cells.

机构信息

Department of Thoracic Surgery, Second Affiliated Hospital, Zhejiang University School of Medicine, 88 Jiefang Road, Shangcheng District, Hangzhou, 310009, China.

出版信息

Med Oncol. 2019 Sep 27;36(11):91. doi: 10.1007/s12032-019-1312-y.

DOI:10.1007/s12032-019-1312-y
PMID:31560089
Abstract

The vasoactive intestinal peptide receptor-1(VIPR1) has prominent growth effects on a number of common neoplasms. However, there were contradictions in the effect cross different cancers. We aimed to explore the effect of VIPR1 overexpression on a human lung adenocarcinoma cell line H1299. GEO dataset was used to screen differentially expressed genes in lung adenocarcinoma tissues. The expression of VIPR1 mRNA was determined in the cancer Genome Atlas (TCGA). Immunohistochemical analysis was performed to determine VIPR1 protein expression in lung adenocarcinoma and corresponding adjacent tissues (n = 22). Fluorescence real-time quantitative PCR detected the expression of VIPR1 in human normal lung epithelial cell line BEAS-2B and lung adenocarcinoma cell line H1299. Overexpression strategies were employed to assess functions of VIPR1 expression on several malignant phenotypes in H1299. The expression of VIPR1 was lower in lung adenocarcinoma tissues than that in adjacent tissues. Compared with the normal lung epithelial cells BEAS-2B, VIPR1 was down-regulated in lung cancer cells H1299 (P < 0.05). After the overexpression of VIPR1, we found that VIPR1 significantly inhibited growth, migration, and invasion of H1299 cells (P < 0.05). Our findings point out the tumor suppressor roles of VIPR1 in human LUAD pathogenesis.

摘要

血管活性肠肽受体-1(VIPR1)对许多常见肿瘤具有显著的生长作用。然而,不同癌症之间的作用存在矛盾。我们旨在探索 VIPR1 过表达对人肺腺癌细胞系 H1299 的影响。GEO 数据集用于筛选肺腺癌组织中差异表达的基因。癌症基因组图谱(TCGA)中确定了 VIPR1 mRNA 的表达。免疫组织化学分析用于确定肺腺癌和相应的相邻组织中 VIPR1 蛋白的表达(n=22)。荧光实时定量 PCR 检测人正常肺上皮细胞系 BEAS-2B 和肺腺癌细胞系 H1299 中 VIPR1 的表达。采用过表达策略来评估 VIPR1 表达对 H1299 中几种恶性表型的功能。肺腺癌组织中 VIPR1 的表达低于相邻组织。与正常肺上皮细胞 BEAS-2B 相比,肺癌细胞 H1299 中 VIPR1 下调(P<0.05)。过表达 VIPR1 后,我们发现 VIPR1 显著抑制 H1299 细胞的生长、迁移和侵袭(P<0.05)。我们的研究结果指出 VIPR1 在人类 LUAD 发病机制中起肿瘤抑制作用。

相似文献

1
Mechanism of VIPR1 gene regulating human lung adenocarcinoma H1299 cells.VIPR1 基因调控人肺腺癌细胞 H1299 的机制。
Med Oncol. 2019 Sep 27;36(11):91. doi: 10.1007/s12032-019-1312-y.
2
miR-186-5p promotes cell growth, migration and invasion of lung adenocarcinoma by targeting PTEN.miR-186-5p 通过靶向 PTEN 促进肺腺癌细胞的生长、迁移和侵袭。
Exp Mol Pathol. 2019 Jun;108:105-113. doi: 10.1016/j.yexmp.2019.04.007. Epub 2019 Apr 11.
3
Oligonucleotide DNA microarray profiling of lung adenocarcinoma revealed significant downregulation and deletions of vasoactive intestinal peptide receptor 1.寡核苷酸 DNA 微阵列分析肺腺癌显示血管活性肠肽受体 1 显著下调和缺失。
Cancer Invest. 2010 Jun;28(5):487-94. doi: 10.3109/07357900903476752.
4
KIF18B as a regulator in microtubule movement accelerates tumor progression and triggers poor outcome in lung adenocarcinoma.KIF18B 作为微管运动的调节剂,可加速肺腺癌的肿瘤进展并引发不良预后。
Tissue Cell. 2019 Dec;61:44-50. doi: 10.1016/j.tice.2019.09.001. Epub 2019 Sep 3.
5
Cancer-testis gene PIWIL1 promotes cell proliferation, migration, and invasion in lung adenocarcinoma.PIWIL1 是一种癌-睾丸基因,可促进肺腺癌中的细胞增殖、迁移和侵袭。
Cancer Med. 2018 Jan;7(1):157-166. doi: 10.1002/cam4.1248. Epub 2017 Nov 23.
6
Knockdown of HSDL2 inhibits lung adenocarcinoma progression via down-regulating AKT2 expression.敲低 HSDL2 通过下调 AKT2 表达抑制肺腺癌进展。
Biosci Rep. 2020 Apr 30;40(4). doi: 10.1042/BSR20200348.
7
Overexpression of geranylgeranyl diphosphate synthase contributes to tumour metastasis and correlates with poor prognosis of lung adenocarcinoma.香叶基二磷酸合酶过表达促进肿瘤转移,并与肺腺癌不良预后相关。
J Cell Mol Med. 2018 Apr;22(4):2177-2189. doi: 10.1111/jcmm.13493. Epub 2018 Jan 29.
8
LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.LPCAT1 通过上调 PI3K/AKT/MYC 通路促进肺腺癌脑转移。
J Exp Clin Cancer Res. 2019 Feb 21;38(1):95. doi: 10.1186/s13046-019-1092-4.
9
Promoter methylation and H3K27 deacetylation regulate the transcription of VIPR1 in hepatocellular carcinoma.启动子甲基化和 H3K27 去乙酰化调节肝癌中 VIPR1 的转录。
Biochem Biophys Res Commun. 2019 Jan 29;509(1):301-305. doi: 10.1016/j.bbrc.2018.12.129. Epub 2018 Dec 22.
10
CASTOR1 suppresses the progression of lung adenocarcinoma and predicts poor prognosis.CASTOR1 抑制肺腺癌的进展并预测不良预后。
J Cell Biochem. 2018 Dec;119(12):10186-10194. doi: 10.1002/jcb.27360. Epub 2018 Aug 21.

引用本文的文献

1
Hypoxia-anoikis-related genes in LUAD: machine learning and RNA sequencing analysis of immune infiltration and therapy response.肺腺癌中与缺氧-失巢凋亡相关的基因:免疫浸润和治疗反应的机器学习与RNA测序分析
Am J Cancer Res. 2025 Aug 25;15(8):3762-3780. doi: 10.62347/GQVA7530. eCollection 2025.
2
Construction of a circRNA-miRNA-mRNA Regulatory Network for the Immune Regulation of Lung Adenocarcinoma.构建用于肺腺癌免疫调节的环状RNA-微小RNA-信使RNA调控网络。
Biol Proced Online. 2025 Apr 10;27(1):13. doi: 10.1186/s12575-025-00275-4.
3
Construction of an immune-related gene prognostic model with experimental validation and analysis of immune cell infiltration in lung adenocarcinoma.

本文引用的文献

1
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
2
Vasoactive intestinal peptide/pituitary adenylate cyclase activating polypeptide, and their receptors and cancer.血管活性肠肽/垂体腺苷酸环化酶激活多肽及其受体与癌症
Curr Opin Endocrinol Diabetes Obes. 2016 Feb;23(1):38-47. doi: 10.1097/MED.0000000000000218.
3
VPAC1 overexpression is associated with poor differentiation in colon cancer.
构建免疫相关基因预后模型并对肺腺癌中的免疫细胞浸润进行实验验证与分析。
Oncol Lett. 2024 May 1;28(1):297. doi: 10.3892/ol.2024.14430. eCollection 2024 Jul.
4
Integrated multi-omics analysis for lung adenocarcinoma in Xuanwei, China.中国宣威肺腺癌的综合多组学分析。
Aging (Albany NY). 2023 Dec 13;15(23):14263-14291. doi: 10.18632/aging.205300.
5
A safety study on ultra‑high or moderate static magnetic fields combined with platycodin D against lung cancer.超高或中等强度静磁场联合桔梗皂苷D抗肺癌的安全性研究
Oncol Lett. 2023 Sep 4;26(4):453. doi: 10.3892/ol.2023.14040. eCollection 2023 Oct.
6
Vasoactive intestinal peptide-VIPR2 signaling regulates tumor cell migration.血管活性肠肽-VIPR2信号传导调节肿瘤细胞迁移。
Front Oncol. 2022 Sep 27;12:852358. doi: 10.3389/fonc.2022.852358. eCollection 2022.
7
Identification of the Diagnostic Biomarker VIPR1 in Hepatocellular Carcinoma Based on Machine Learning Algorithm.基于机器学习算法的肝细胞癌诊断生物标志物血管活性肠肽受体1的鉴定
J Oncol. 2022 Sep 15;2022:2469592. doi: 10.1155/2022/2469592. eCollection 2022.
8
lncRNA-AC079061.1/VIPR1 axis may suppress the development of hepatocellular carcinoma: a bioinformatics analysis and experimental validation.lncRNA-AC079061.1/VIPR1 轴可能抑制肝细胞癌的发展:生物信息学分析和实验验证。
J Transl Med. 2022 Aug 29;20(1):379. doi: 10.1186/s12967-022-03573-7.
9
Identification of Hub Genes of Lung Adenocarcinoma Based on Weighted Gene Co-Expression Network in Chinese Population.基于中国人群的加权基因共表达网络鉴定肺腺癌的枢纽基因。
Pathol Oncol Res. 2022 Aug 10;28:1610455. doi: 10.3389/pore.2022.1610455. eCollection 2022.
10
MiR-96-5p Facilitates Lung Adenocarcinoma Cell Phenotypes by Inhibiting FHL1.miR-96-5p 通过抑制 FHL1 促进肺腺癌细胞表型。
Comput Math Methods Med. 2022 Aug 16;2022:7891222. doi: 10.1155/2022/7891222. eCollection 2022.
血管活性肠肽受体1(VPAC1)过表达与结肠癌的低分化相关。
Tumour Biol. 2014 Jul;35(7):6397-404. doi: 10.1007/s13277-014-1852-x. Epub 2014 Mar 28.
4
VIPhyb, an antagonist of vasoactive intestinal peptide receptor, enhances cellular antiviral immunity in murine cytomegalovirus infected mice.VIPhyb,血管活性肠肽受体拮抗剂,增强了感染鼠巨细胞病毒的小鼠的细胞抗病毒免疫。
PLoS One. 2013 May 27;8(5):e63381. doi: 10.1371/journal.pone.0063381. Print 2013.
5
Innovative community-based approaches doubled tuberculosis case notification and improve treatment outcome in Southern Ethiopia.创新的基于社区的方法使埃塞俄比亚南部的结核病病例通知增加了一倍,并改善了治疗效果。
PLoS One. 2013 May 27;8(5):e63174. doi: 10.1371/journal.pone.0063174. Print 2013.
6
Pituitary adenylate cyclase-activating polypeptide causes tyrosine phosphorylation of the epidermal growth factor receptor in lung cancer cells.垂体腺苷酸环化酶激活肽导致肺癌细胞中表皮生长因子受体的酪氨酸磷酸化。
J Pharmacol Exp Ther. 2012 Jun;341(3):873-81. doi: 10.1124/jpet.111.190033. Epub 2012 Mar 2.
7
Gene expression of vasoactive intestinal peptide receptors in human lung cancer.血管活性肠肽受体在人肺癌中的基因表达。
Int J Oncol. 2011 Oct;39(4):1019-24. doi: 10.3892/ijo.2011.1122. Epub 2011 Jul 13.
8
Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship.非小细胞肺癌:流行病学、危险因素、治疗及生存情况。
Mayo Clin Proc. 2008 May;83(5):584-94. doi: 10.4065/83.5.584.
9
Expression of vasoactive intestinal peptide and functional VIP receptors in human prostate cancer: antagonistic action of a growth-hormone-releasing hormone analog.血管活性肠肽及功能性血管活性肠肽受体在人前列腺癌中的表达:生长激素释放激素类似物的拮抗作用
Int J Oncol. 2005 Jun;26(6):1629-35. doi: 10.3892/ijo.26.6.1629.
10
Human H9 cells proliferation is differently controlled by vasoactive intestinal peptide or peptide histidine methionine: implication of a GTP-insensitive form of VPAC1 receptor.血管活性肠肽或肽组氨酸甲硫氨酸对人H9细胞增殖的调控存在差异:一种对GTP不敏感的VPAC1受体的影响
J Neuroimmunol. 2005 Jan;158(1-2):94-105. doi: 10.1016/j.jneuroim.2004.08.018.